NO2496261T3 - - Google Patents

Info

Publication number
NO2496261T3
NO2496261T3 NO10828966A NO10828966A NO2496261T3 NO 2496261 T3 NO2496261 T3 NO 2496261T3 NO 10828966 A NO10828966 A NO 10828966A NO 10828966 A NO10828966 A NO 10828966A NO 2496261 T3 NO2496261 T3 NO 2496261T3
Authority
NO
Norway
Application number
NO10828966A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2496261T3 publication Critical patent/NO2496261T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
NO10828966A 2009-11-05 2010-11-02 NO2496261T3 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25839109P 2009-11-05 2009-11-05
PCT/US2010/055068 WO2011056775A2 (fr) 2009-11-05 2010-11-02 Compositions de cellulose microcristalline et de phosphate de calcium utiles en tant qu'excipients pharmaceutiques

Publications (1)

Publication Number Publication Date
NO2496261T3 true NO2496261T3 (fr) 2018-05-19

Family

ID=43925704

Family Applications (1)

Application Number Title Priority Date Filing Date
NO10828966A NO2496261T3 (fr) 2009-11-05 2010-11-02

Country Status (10)

Country Link
US (1) US8329221B2 (fr)
EP (1) EP2496261B1 (fr)
JP (1) JP6092626B2 (fr)
BR (1) BR112012010400B1 (fr)
DK (1) DK2496261T3 (fr)
ES (1) ES2662698T3 (fr)
IL (1) IL219374B (fr)
NO (1) NO2496261T3 (fr)
TW (1) TWI461213B (fr)
WO (1) WO2011056775A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2387993B1 (fr) * 2010-05-21 2012-11-07 Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi Comprimés à désintégration orale de zolmitriptan et son procédé de préparation
BR112017024265B1 (pt) * 2015-05-11 2022-08-09 Mybiotics Pharma Ltd Métodos para crescimento de um biofilme de bactérias probióticas em partículas sólidas
EP3697392B1 (fr) 2017-10-17 2023-11-15 Synthon B.V. Comprimés comprenant de la tamsulosine et de la solifénacine
BR112020016884A2 (pt) 2018-02-26 2020-12-15 R.P. Scherer Technologies, Llc Forma de dosagem farmacêutica para uma emulsão de simeticona e loperamida
KR102868121B1 (ko) 2018-03-22 2025-10-14 코미팜 인터내셔널 오스트레일리아 피티와이 엘티디 메타 아비산염을 포함하는 약학 조성물 및 제조 방법
CN108815125A (zh) * 2018-07-23 2018-11-16 深圳市优普惠药品股份有限公司 微晶纤维素与无水磷酸氢钙复合物及其制备工艺
US12115259B2 (en) 2018-10-04 2024-10-15 Chemische Fabrik Budenheim Kg Spherical beads for use in producing pharmaceutically active pellets
EP3892262A1 (fr) 2020-04-06 2021-10-13 Chemische Fabrik Budenheim KG Billes comprenant un système de tampon
MX2022013258A (es) * 2020-04-24 2022-11-14 Astrazeneca Ab Formulaciones farmaceuticas.
JP2023533903A (ja) * 2020-05-15 2023-08-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 Ｆｇｆｒ４阻害剤の経口製剤によるがんの治療方法
CN115120566A (zh) * 2021-03-26 2022-09-30 北京济美堂医药研究有限公司 一种含瑞格列奈的口服药物制剂
CN115671299A (zh) * 2022-11-17 2023-02-03 湖州展望药业有限公司 一种微晶纤维素无水磷酸氢钙共处理物的制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002521A1 (fr) 1980-03-10 1981-09-17 Mendell Co Inc Edward Composition de vehicule pharmaceutique et son procede de production
US4517179A (en) 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
CA1261261A (fr) * 1985-03-08 1989-09-26 Dev K. Mehra Composition microcristalline de cellulose et de carbonate de calcium cotraites, et sa preparation
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US6936277B2 (en) 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6123964A (en) * 1995-10-27 2000-09-26 Merck & Co., Inc. Wet granulation formulation of a growth hormone secretagogue
US5858409A (en) 1996-04-17 1999-01-12 Fmc Corporation Hydrolyzed cellulose granulations for pharmaceuticals
US5747067A (en) 1996-12-06 1998-05-05 Fmc Corporation Co-processed products
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6716449B2 (en) 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
US20010053791A1 (en) 2000-03-16 2001-12-20 Babcock Walter C. Glycogen phosphorylase inhibitor
AT5874U1 (de) 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
EP1226818A1 (fr) 2001-01-26 2002-07-31 Pfizer Products Inc. Formulation pharmaceutique présentant des propriétés de cohesion et de compressibilité améliorées
PT1476136E (pt) * 2002-02-14 2006-10-31 Glaxo Group Ltd Composicao farmaceutica compreendendo n-((1-n-butil-4-piperidinil)metil)-3,4-di-hidro-2h-(1,3) oxazino (3,2-a) indole-10-carboxamida ou sal e processo de a obter compreendendo granulacao a seco.
TW200403994A (en) 2002-04-04 2004-03-16 Bristol Myers Squibb Co Oral administration of EPOTHILONES
GB0211620D0 (en) 2002-05-21 2002-07-03 Bioprogress Technology Ltd Powder compaction and enrobing
GB0322358D0 (en) 2003-09-24 2003-10-22 Bioprogress Technology Ltd Improvements in powder compaction and enrobing
WO2006032828A1 (fr) 2004-09-24 2006-03-30 Bioprogress Technology Limited Nouvelles améliorations dans le compactage et l’enrobage de poudres
JP3841804B2 (ja) 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
DE102005046146A1 (de) * 2005-02-25 2006-08-31 Bayerische Motoren Werke Ag Teilintegralbremse für ein Motorrad
WO2007062338A2 (fr) * 2005-11-18 2007-05-31 Astrazeneca Ab Formulations solides
US7998505B2 (en) 2006-10-27 2011-08-16 Fmc Corporation Dry granulation binders, products, and use thereof
CA2644179C (fr) * 2007-11-21 2018-09-25 Pharmascience Inc. Composition pharmaceutique inedite comprenant une matrice de desintegration

Also Published As

Publication number Publication date
BR112012010400B1 (pt) 2019-11-05
US20110104288A1 (en) 2011-05-05
DK2496261T3 (en) 2018-03-26
BR112012010400A2 (pt) 2016-07-12
WO2011056775A3 (fr) 2011-11-03
JP2013510157A (ja) 2013-03-21
EP2496261A2 (fr) 2012-09-12
ES2662698T3 (es) 2018-04-09
EP2496261B1 (fr) 2017-12-20
EP2496261A4 (fr) 2014-03-26
WO2011056775A2 (fr) 2011-05-12
JP6092626B2 (ja) 2017-03-08
IL219374A0 (en) 2012-06-28
TWI461213B (zh) 2014-11-21
US8329221B2 (en) 2012-12-11
TW201124157A (en) 2011-07-16
IL219374B (en) 2019-05-30

Similar Documents

Publication Publication Date Title
BE2015C040I2 (fr)
BRPI0925311A2 (fr)
BR112012008195A2 (fr)
BR112012008267A2 (fr)
BR112012012396A2 (fr)
BR112012012487A2 (fr)
BR112012003853A2 (fr)
BR112012012080A2 (fr)
BRPI0924534A2 (fr)
BR112012009797A2 (fr)
BR112012009446A2 (fr)
BR112012009703A2 (fr)
BR112012010357A2 (fr)
BR112012001263A2 (fr)
BR112012007656A2 (fr)
BRPI1004942A2 (fr)
BR112012014856A2 (fr)
BR112012002627A2 (fr)
BR112012007654A2 (fr)
BR112012005951A2 (fr)
BR112012007672A2 (fr)
BR112012000156A2 (fr)
BR112012007671A2 (fr)
BR112012009404A2 (fr)
BRPI0925022A2 (fr)